Human Reproduction, Vol. 18, No. 4, 744-748,
April 2003
© 2003 European Society of Human Reproduction and Embryology
Changes in circulating concentrations of inhibins A and pro-
C during first trimester medical termination of pregnancy
Academic Unit of Obstetrics and Gynaecology, University Department of Reproductive and Developmental Medicine, The Jessop Wing, Tree Root Walk, Sheffield S10 2SF, UK
1 To whom correspondence should be addressed. e-mail: W.Ledger{at}Sheffield.ac.uk
BACKGROUND: Both inhibin A and inhibin pro-
C are detectable in the circulation in increasing amounts during establishment of pregnancy. However, their origins and functions remain to be elucidated. We have studied levels of inhibin A and inhibin pro- C in serum samples collected at various stages during medical termination of pregnancy with consecutive use of mifepristone and misoprostol. METHODS: Samples were collected from three groups of patients at different weeks of gestation (group A: 6–7 weeks, n = 6; group B: 7–8 weeks, n = 6; group C: 8–9 weeks, n = 6) at the time of administration of oral mifepristone, 48 h later just before administration of vaginal misoprostol and again soon after expulsion of the products of conception. Plasma concentrations of inhibin A and pro- C were assayed using specific and sensitive enzyme-linked immunosorbent assays. Results were correlated with concentrations of hCG and progesterone. RESULTS: We observed a significant fall in plasma concentration of inhibin pro- C following administration of mifepristone, which continued after administration of misoprostol. In contrast mifepristone had no effect on plasma levels of inhibin A, which fell steeply only after administration of misoprostol. CONCLUSIONS: These results suggest dissociation between major sources of inhibin A and inhibin pro- C in early pregnancy. Treatment with mifepristone, a competitive antagonist of the progesterone receptor, resulted in a significant and rapid fall in concentrations of inhibin pro- C, identifying a link between production of pro- C and luteal steroidogenesis. In contrast, concentrations of inhibin A did not fall after mifepristone, identifying a predominantly feto-placental origin in early human pregnancy.
Key words: inhibin A/pro- C/pregnancy/medical termination
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Tong, L. Rombauts, J. Onwude, B. Marjono, and E.M. Wallace Highly specific and sensitive rise in Days 14 17 pro-{alpha}C inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles Hum. Reprod., August 1, 2007; 22(8): 2249 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Elson, A. Tailor, R. Salim, K. Hillaby, T. Dew, and D. Jurkovic Expectant management of miscarriage--prediction of outcome using ultrasound and novel biochemical markers Hum. Reprod., August 1, 2005; 20(8): 2330 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vaisanen-Tommiska, T. S. Mikkola, and O. Ylikorkala Increased Release of Cervical Nitric Oxide in Spontaneous Abortion before Clinical Symptoms: A Possible Mechanism for Preabortal Cervical Ripening J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5622 - 5626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468. [Abstract] [Full Text] [PDF]
|
|